7:00 a.m. – 9:00 a.m

Registration & Continental Breakfast

9:00 a.m. – 9:30 a.m

Opening Remarks
Timothy P. Condon, Ph.D.
Deputy Director, National Institute on Drug Abuse, National Institute of Health

Introductions
Dennis M. Donovan, Ph.D.
Director, Drug and Alcohol Abuse Institute, University of Washington School of Medicine
 
Dennis McCarty, Ph.D., Professor
Department of Public Health & Preventive Medicine, Oregon Health & Science University

Welcoming Speaker
Robin Arnold-Williams, D.S.W.
Secretary, Washington State Department of Social and Health Services

9:30 a.m. – 11:00 a.m

Plenary Presentation

Moving From Bench to Bedside to Community:
Research-Practice Partnerships Are Making It Possible
Nora D. Volkow, M.D.
Director, National Institute on Drug Abuse, National Institutes of Health

11:00 a.m. – 11:15 a.m.

Break

11:15 a.m. – 12:45 p.m.


Session 1


 

Session 2





Session 3
 

Session 4

Session 5

Session 6

Morning Breakout Sessions

S.M.A.R.T. Treatment Planning Using the ASI:  Perspectives on Research, Dissemination, and Provider Application
Deni Carise, Ph.D.
Pat Stilen, LCSW, CADAC
Ron Jackson, M.S.W.

Healing Co-Occurring Trauma and Substance Use in Adolescents
Cynthia L. Rowe, Ph.D.
Lucy Zammarelli, M.A.

Challenges in Determining Best Practices in Criminal Justice
Michele Staton-Tindall, Ph.D., M.S.W.
Patricia Noble-Desy, M.A.
Felisia Otis

Neurocognition and Methamphetamine Dependence
Sara L. Simon, Ph.D.
Andrew J. Saxon, M.D.
Lisa C. Romwall, M.A., CDP

Integrated Treatment for Trauma and Addiction: Seeking Safety
Denise Hien, Ph.D.
Tracy L. Simpson, Ph.D.

The Role of Clinical Supervision in Learning, Adopting, and Maintaining Evidence-Based Practice
Kathleen M. Carroll, Ph.D.
Kathyleen Tomlin, L.P.C., CADC III

12:45 p.m. – 2:30 p.m.

Lunch Presentation
Research on Genetics of Addiction: Critical Role of and Rewards for Clinicians
Mary Jeanne Kreek, M.D.
Patrick E. and Beatrice M. Haggerty, Professor, Head of the Laboratory of the Biology of Addictive Diseases, The Rockefeller University Senior Physician, The Rockefeller University Hospital

2:30 p.m. – 2:45 p.m

Break

2:45 p.m. – 4:00 p.m.

Session 7
 

Session 8
 

Session 9

Session 10

Session 11



Session 12

Afternoon Breakout Sessions

Understanding and Utilizing Buprenorphine in the Treatment of Opioid Addiction
Susan A. Storti, Ph.D., R.N. Part 1
Susan A. Storti, Ph.D., R.N. Part 2
Joshua Boverman, M.D.
Andrew J. Saxon, M.D.
Bill Dickinson, D.O., FASAM, FAAFP

Drug Courts: What is the Evidence?
Douglas B. Marlowe, J.D., Ph.D.
Norma D. Jaeger, M.S.

What can Neuroscience Offer Addiction Treatment?
William F. Hoffman, M.D., Ph.D.
Glen R. Hanson, Ph.D., D.D.S.
Jeanne Obert, M.F.T., MSM

What is Gender-Specific Treatment for Women?
Shelly Greenfield, M.D., M.P.H.
Sharon A. Chambers, M.S.W., LICSW, CDP

How is Evidence-Based Practice Defined and What Does it Mean to Implement Evidence-Based Practices
Dean Fixsen, Ph.D.
William R. Miller,Ph.D.
Joan E. Zweben, Ph.D.

4:00 p.m. - 4:15 p.m.

Afternoon Coffee Break

4:15 p.m. – 5:30 p.m.

See Afternoon Breakout Sessions

5:30 p.m.

Adjourn